相关实验视频
Updated: May 26, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
437
溶性酸环酶作为慢性病的药理缓解的直接目标
1Unit of Cardiovascular and Renal Research, Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Kidney international
|February 21, 2025
概括
BAY-60-2770,一种激活可溶性瓜尼利环酶的药物,减少了大鼠的炎和损伤. 这种药物改善了脏的血液流动和血管功能,而不影响血压,为脏疾病提供了潜在的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 氧化应激可以使可溶性瓜尼利基循环酶 (sGC) 失活,这是对血管功能至关重要的酶.
- 损伤,炎症和纤维化是缺血-再输血的重要并发症.
- 慢性病 (CKD) 的进展仍然是一个主要的健康问题,治疗选择有限.
研究的目的:
- 为了研究BAY-60-2770的治疗潜力,一个sGC激活剂,在减轻脏损伤.
- 为了评估BAY-60-2770对脏血管功能在缺血-再输血损伤后的影响.
- 探索sGC作为阻止CKD进展的潜在治疗点.
主要方法:
- 使用了脏缺血-再输液损伤的临床前小鼠模型.
- 评估了BAY-60-2770对脏炎症,损伤和纤维化的影响.
- 测量了 perfusion,血管反应力和微血管直径.
- 对包括血压在内的血液动力学参数进行了监测.
主要成果:
- BAY-60-2770显著减轻了脏炎症,损伤和纤维化.
- 该药物改善了 perfusion,整体血管反应能力和髓微血管直径.
- 这些有益效应在剂量没有改变全身血压的情况下被观察到.
- BAY-60-2770在缺血症-再输血后显示出具有保护性血管效应.
结论:
- 用BAY-60-2770激活可溶性瓜尼利基环酶为脏保护提供了一个有前途的治疗策略.
- BAY-60-2770通过改善血管功能来改善损伤,特别是在缺血-再输血后.
- 溶性瓜尼利基环酶是一种有价值的,但尚未充分利用的治疗点,用于控制和阻止慢性病的进展.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
Open Angle Glaucoma: Treatment
384
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
384

